Epiterna Overview
- Year Founded
-
2022
- Status
-
Out of Business
- Latest Deal Type
-
Liquidation
Epiterna General Information
Description
Developer of medicinal products designed for treating diseases of animals and humans. The company uses a drug screening platform to produce products that can safely slow aging, prevent age-related disease, and delay functional decline, enabling users to extend their lives.
Contact Information
Website
www.epiterna.comCorporate Office
- Route de la Corniche 5A
- 1066 Epalinges
- Switzerland
Corporate Office
- Route de la Corniche 5A
- 1066 Epalinges
- Switzerland
Epiterna Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Bankruptcy: Liquidation | 18-Feb-2026 | Completed | Bankruptcy: Liquidation | |||
| 1. Seed Round | 02-Aug-2023 | Completed | Generating Revenue |
Epiterna FAQs
-
When was Epiterna founded?
Epiterna was founded in 2022.
-
Where is Epiterna headquartered?
Epiterna is headquartered in Epalinges, Switzerland.
-
What industry is Epiterna in?
Epiterna’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Epiterna a private or public company?
Epiterna is a Private company.
-
What is Epiterna’s current revenue?
The current revenue for Epiterna is .
-
How much funding has Epiterna raised over time?
Epiterna has raised $11.1M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process